Composition of the Stroma in the Human Endometrium and Endometriosis

To analyze whether the endometrial and endometriotic microenvironment is involved in the pathogenesis of endometriosis, we characterized the stromal composition. We used CD90 for fibroblasts, α-smooth muscle actin for myofibroblasts as well as CD10 and CD140b for mesenchymal stromal cells. Quantification of eutopic endometrial stroma of cases without endometriosis showed a high percentage of stromal cells positive for CD140b (80.7%) and CD10 (67.4%), a moderate number of CD90-positive cells (57.9%), and very few α-smooth muscle actin-positive cells (8.5%). These values are highly similar to cases with endometriosis showing only minor changes: CD140b (76.7%), CD10 (63%), CD90 (53.9%), and α-smooth muscle actin (6.9%). There are no significant differences in the composition of CD140b- and CD10-positive stromal cells between the eutopic endometrial stroma and the 3 different endometriotic entities (ovarian, peritoneal, and deep infiltrating endometriosis), except for a significant difference between CD10-positive stromal cells in peritoneal lesions compared to ovarian lesions. However, the percentage of CD90-positive stromal cells was reduced in the 3 different endometriotic entities compared to the endometrium, especially significant in the ovarian lesions. In contrast, the percentage of α-smooth muscle actin-positive cells in the ovary was moderately increased. Taken together, the marker signature of eutopic endometrial and endometriotic stromal cells resembles mostly mesenchymal stromal cells. Our results show clearly that the proportion of the different stromal cell types in the endometrium with or without endometriosis does not differ significantly, thus suggesting that the stromal eutopic endometrial micro-environment does not contribute to the pathogenesis of endometriosis. Similar content being viewed by others

Doljanski F. The sculpturing role of fibroblast-like cells in morphogenesis. Perspect Biol Med. 2004;47(3):339–356. Bianco P. “Mesenchymal” stem cells. Ann Rev Cell Dev Biol. 2014;30:677–704. Tarin D. Role of the host stroma in cancer and its therapeutic significance. Cancer Metastasis Rev. 2013;32(3–4):533–566. Bani D, Nistri S. New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. Lessons from the heart. J Cell Mol Med. 2014;18(3):363–370. Kolonin MG, Evans KW, Mani SA, Gomer RH. Alternative origins of stroma in normal organs and disease. Stem Cell Res. 2012;8(2):312–323. Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:1–13. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317. Lee WS, Jain MK, Arkonac BM, et al. Thy-1, a novel marker for angiogenesis is upregulated by inflammatory cytokines. Circ Res. 1998;82(8):845–851. Kretschmer S, Dethlefsen I, Hagner-Benes S, et al. Visualization of intrapulmonary lymph vessels in healthy and inflamed murine lung using CD90/Thy-1 asamarker. Plos One. 2013;8(2):e55201. Österreicher CH, Penz-Österreicher M, Grivennikov SI, et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci U S A. 2011;108(1):308–313. Kong P, Christia P, Saxena A, Frangogiannis NG. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol. 2013;305(9):H1363–H1372. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol. 2010;42(4):535–542. Barth PJ, Ramaswamy A, Moll R. CD34+ fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch. 2002;441(6):564–568. Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology. Am J Pathol. 2012;180(4):1340–1355. Eyden B, Banerjee SS, Shenjere P, Fisher C. The myofibroblast and its tumours. J Clin Pathol. 2009;62(3):236–249. Lin CS, Xin ZC, Dai J, Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol Histopathol. 2013;28(9):1109–1116. Bühring HJ, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci. 2007;1106:262–271. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2(4):313–319. McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 2001;39(3):273–278. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP. Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(—) human female reproductive tract fibroblasts. Am J Pathol. 2001;159(3):925–935. Schwab KE, Hutchinson P, Gargett CE. Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod. 2008;23(4):934–943. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod. 2007;22(11):2903–2911. Czernobilsky B, Remadi S, Gabbiani G. Alpha-smooth muscle actin and other stromal markers in endometrial mucosa. Virchows Arch A Pathol Anat Histopathol. 1993;422(4):313–317. McCuaig R, Wu FW, Dunn J, Rao S, Dahlstrom JE. The biological and clinical significance of stromal-epithelial interactions in breast cancer. Pathology. 2017;49(2):133–140. Boyle DP, McCluggage WG. Peritoneal stromal endometriosis: a detailed morphological analysis of a large series of cases of a common and under-recognised form of endometriosis. J Clin Pathol. 2009;62(6):530–533. Haas D, Chvatal R, Habelsberger A, Wurm P, Schimetta W, Oppelt P. Comparison of revised American Fertility Society and ENZIAN staging: a critical evaluation of classifications of endometriosis on the basis of our patient population. Fertil Steril. 2011;95(5):1574–1578. Konrad L, Scheiber JA, Volck-Badouin E, et al. Alternative splicing of TGF-betas and their high-affinity receptors TβRI, TβRII and TβRIII (Betaglycan) reveal new variants in human prostatic cells. BMC Genomics. 2007;8:318. Magguer-Satta V, Besancon R, Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multi-faceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells. 2011;29(3):389–396. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood. 1991;78(7):1834–1841. Oliva E. CD10 expression in the female genital tract: does it have useful diagnostic applications? Adv Anat Pathol. 2004;11(6):310–315. Sumathi VP, McGluggage WG. CD10 is useful in demonstrating endometrial stroma at ectopic sites and in confirming a diagnosis of endometriosis. J Clin Pathol. 2002;55(5):391–392. Groisman GM, Meir A. CD10 is helpful in detecting occult or inconspicuous endometrial stromal cells in cases of presumptive endometriosis. Arch Pathol Lab Med. 2003;127(8):1003–1006. Srodon M, Klein WM, Kurman RJ. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol. 2003;27(6):786–789. Capobianco G, Wenger JM, Marras V, et al. Immunohistochemical evaluation of epithelial antigen Ber-Ep4 and Cd10: new markers for endometriosis? Eur J Gynaecol Oncol. 2013;34(3):254-246. Iwase A, Kotani T, Goto M, et al. Possible involvement of CD10 in the development of endometriosis due to its inhibitory effects on CD44-dependent cell adhesion. Reprod Sci. 2014;21(1):82–88. Bachelard-Cascales E, Chapellier M, Delay E, et al. The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells. 2010;28(6):1081–1088. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22(10):1276–1312. Cao Y. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis. Trends Mol Med. 2013;19(8):460–473. Chegini N, Rossi MJ, Masterson BJ. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGFb-receptors in human endometrial tissue: localization and in vitro action. Endocrinology. 1992;130(4):2373–2385. Ferrero S, Alessandri F, Racca A, Leone Roberti Maggiore U. Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril. 2015;104(4):771–792. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 1999;190(1–2):105–118. Orlandi A, Ferlosio A, Ciucci A, et al. Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications. Histopathology. 2004;45(5):511–517. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Konrad, L., Kortum, J., Nabham, R. et al. Composition of the Stroma in the Human Endometrium and Endometriosis. Reprod. Sci. 25, 1106–1115 (2018). https://doi.org/10.1177/1933719117734319 Published: Version of record: Issue date: DOI: https://doi.org/10.1177/1933719117734319